AMD risk is increased in carriers of genetic variants that affect different aspects of the complement system, including negative regulation of complement activation (CFH and CFI), convertase formation (complement factor B (CFB), C2 and C3) and MAC (C5b-9) formation11–16. This evidence concerns the gene C3 and age-related macular degeneration.